ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines

• click to rate

  Posted by Two Blokes Jul 16 - Filed in Stock - 1 view
  
  AngioDynamics beats fourth-quarter fiscal 2025 estimates with strong Med Tech growth amid margin declines and a wider fiscal 2026 loss outlook.